cabergoline has been researched along with Endometrioma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 7 (43.75) | 2.80 |
| Authors | Studies |
|---|---|
| Angioni, S; Carugno, J; Ciebiera, M; Ćorić, M; D'alterio, MN; Herman, M; Mikuš, M; Puževski, T; Vitale, SG; Zajec, V | 1 |
| Karasu, AFG; Karslıoglu, T; Yildiz, P | 1 |
| Casarin, J; Cromi, A; Franchi, M; Garzon, S; Ghezzi, F; Laganà, AS; Raffaelli, R | 1 |
| Ekici, Eİ; Güney, M; Nazıroğlu, M | 1 |
| Kogan, I; Molotkov, A; Suslova, E; Tkachenko, N; Yarmolinskaya, M | 1 |
| Arce, JC; Bagger, YZ; Galliano, D; Herraiz, S; Pellicer, A; Pellicer, N | 1 |
| Imanaka, S; Kimura, M; Kobayashi, H; Maruyama, S; Nagayasu, M | 1 |
| Fatemi, F; Jouhari, S; Khazali, S; Lakpour, N; Mirzadegan, E; Mohammadi, Z; Mohammadzadeh, A; Mohazzab, A; Naderi, MM; Soltanghoraee, H; Zafardoust, S | 1 |
| Bougeret, C; Corachán, A; Domínguez, F; Ferrero, H; Pellicer, A; Pouletty, P; Quiñonero, A | 1 |
| Elzaher, MA; Hamid, AM; Madkour, WA; Moawad, A; Roberts, MP | 1 |
| Aydogan, U; Cengiz, M; Ercan, CM; Ergun, A; Ide, T; Kayaalp, O; Keskin, U; Yumusak, N | 1 |
| Benedetto, C; Brossa, A; Bussolati, B; Canosa, S; Leoncini, S; Marchino, GL; Moggio, A; Pittatore, G; Revelli, A | 1 |
| Carda, C; García-Velasco, JA; Noguera, I; Novella-Maestre, E; Pellicer, A; Ruiz-Saurí, A; Simón, C | 1 |
| Carda, C; Garcia-Velasco, JA; Novella-Maestre, E; Pellicer, A; Ruiz-Sauri, A; Simon, C | 1 |
| Delgado-Rosas, F; Ferrero, H; Garcia-Velasco, J; Gaytan, F; Gómez, R; Pellicer, A; Simón, C | 1 |
| Carda, C; Herraiz, S; Novella-Maestre, E; Pellicer, A; Ruiz-Sauri, A; Vila-Vives, JM | 1 |
3 review(s) available for cabergoline and Endometrioma
| Article | Year |
|---|---|
State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials.
Topics: Cabergoline; Dopamine Agonists; Endometriosis; Female; Humans; Pelvic Pain | 2022 |
Use of dopamine agonists to target angiogenesis in women with endometriosis.
Topics: Cabergoline; Dopamine Agonists; Endometriosis; Endometrium; Female; Humans; Pregnancy; Vascular Endothelial Growth Factor A | 2021 |
Nonhormonal Treatment for Endometriosis Focusing on Redox Imbalance.
Topics: Animals; Antioxidants; Cabergoline; Dopamine Agonists; Endometriosis; Female; Glucosides; Humans; Methemoglobin; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Signal Transduction; Simvastatin; Stilbenes; Superoxides | 2021 |
3 trial(s) available for cabergoline and Endometrioma
| Article | Year |
|---|---|
The Effects of Micronized Progesterone and Cabergoline On a Rat Autotransplantation Endometriosis Model: A Placebo Controlled Randomized Trial.
Topics: Animals; Cabergoline; Disease Models, Animal; Endometriosis; Female; Humans; Progesterone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Transplantation, Autologous | 2021 |
Dopamine agonists as genital endometriosis target therapy.
Topics: Adult; Ascitic Fluid; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Molecular Targeted Therapy; Pelvic Pain; Peritoneal Diseases; Prolactin; Russia; Syndrome; Treatment Outcome | 2020 |
Does cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study.
Topics: Administration, Oral; Adult; Cabergoline; Dopamine Agonists; Endometriosis; Ergolines; Female; Genital Diseases, Female; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Luteolytic Agents; Magnetic Resonance Imaging; Prospective Studies; Triptorelin Pamoate; Ultrasonography | 2014 |
10 other study(ies) available for cabergoline and Endometrioma
| Article | Year |
|---|---|
Know Your Enemy: Potential Role of Cabergoline to Target Neoangiogenesis in Endometriosis.
Topics: Cabergoline; Endometriosis; Female; Humans; Neovascularization, Pathologic | 2021 |
Protective effect of cabergoline on mitochondrial oxidative stress-induced apoptosis is mediated by modulations of TRPM2 in neutrophils of patients with endometriosis.
Topics: Adult; Apoptosis; Cabergoline; Dopamine Agonists; Endometriosis; Female; Humans; Mitochondria; Neutrophils; Oxidative Stress; TRPM Cation Channels | 2020 |
Effects of silymarin, cabergoline and letrozole on rat model of endometriosis.
Topics: Animals; Antioxidants; Aromatase Inhibitors; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Female; Letrozole; Random Allocation; Rats; Rats, Sprague-Dawley; Silymarin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |
Inhibition of KIF20A by BKS0349 reduces endometriotic lesions in a xenograft mouse model.
Topics: Animals; Apoptosis; Cabergoline; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Heterografts; Humans; Kinesins; Mice; Mice, Nude; Optical Imaging; Peritoneal Diseases | 2019 |
Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Laparotomy; Leuprolide; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Triptorelin Pamoate | 2015 |
Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
Topics: Angiogenesis Inhibitors; Biomarkers; Cabergoline; Cadherins; Cell Communication; Cell Differentiation; Cell Proliferation; Coculture Techniques; Endometriosis; Endometrium; Ergolines; Female; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cells; Models, Biological; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Primary Cell Culture; Proto-Oncogene Proteins c-myc; Receptor, TIE-2; Syndecan-2; Vascular Endothelial Growth Factor Receptor-2; Vimentin | 2017 |
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Topics: Animals; Cabergoline; Cell Proliferation; Disease Models, Animal; Dopamine Agonists; Endometriosis; Ergolines; Female; Gene Expression Regulation; Humans; Mice; Neovascularization, Pathologic; Phosphorylation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy.
Topics: Adolescent; Adult; Animals; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Ergolines; Female; Gene Expression Regulation; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Oocyte Donation; Receptors, Dopamine D2; Severity of Illness Index; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors; Young Adult | 2010 |
The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Topics: Animals; Blood Vessels; Cabergoline; Cell Count; Cell Proliferation; Claviceps; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Humans; Mice; Neovascularization, Pathologic; Receptors, Dopamine D2; Uterine Diseases; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Effect of antiangiogenic treatment on peritoneal endometriosis-associated nerve fibers.
Topics: Actins; Angiogenesis Inhibitors; Animals; Biomarkers; Cabergoline; Disease Models, Animal; Endometriosis; Endometrium; Ergolines; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Macrophages; Mast Cells; Mice; Mice, Nude; Microvessels; Neovascularization, Pathologic; Nerve Fibers; Ovariectomy; Peritoneal Diseases; Time Factors; von Willebrand Factor | 2012 |